GLP-1RA Liraglutide Semaglutide Efpeglenatide Glucose lowering effect CV system protection effect Kidney protection effect Nonalcoholic fatty liver disease GIP/GLP1 receptor coagonists: tirzepatide Amylin/GLP1 receptor coagonists: CagriSema (cagrilintide+semaglutide) Glucagon/GLP1 receptor coagonists: survodutide GIP/GLP1/glucagon receptor triple coagonists: retatrutide Obesity is a disease that can be treated with targeted pharmacotherapy in addition to lifestyle modification and behavioral interventions
The most common are digestive issues (stomach-related), particularly when first starting treatment or after increasing the dose
Growth hormone secretagogues, like those studied in the CJC-1295/Ipamorelin research guide, target the GH/IGF-1 axis rather than incretin pathways and may be studied alongside GLP-1 class compounds for their complementary effects on body composition
You dont have to give up rice, roti, or dal, but we focus on portion control, adding more vegetables, and choosing healthier cooking methods
May 20, 2026: How GLP-1s Like Ozempic Turn Down Food Noise to Help You Lose Weight May 19, 2026: Wegovy: Semaglutide Reduces Migraine Severity, Especially in Women May 11, 2026: Weight Loss Surgeries Decline as GLP-1 Use Skyrockets
Persistent redness lasting more than 48 hours, significant swelling greater than a toonie in diameter, itching that interferes with daily activities, or formation of hard lumps at injection sites deserve attention
![GLP-1 users, meet your new best friend! 🤝 📚 Studies show most US adults lack Vitamins A, C, D, E, K, calcium, and magnesium in their daily diet.[4] 🍽️ People who lose weight or use GLP-1 meds often](https://www.tiktok.com/api/img/?itemId=7549518624776523038&location=0&aid=1988)
